Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Therapeuticsmd Inc (TXMD)  
$1.89 0.01 (0.53%) as of 4:30 Thu 4/18


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 296,250,000
Market Cap: 559.91(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.89 - $4.49
Level I Sector: Energy
Level II Sector: Energy
Level III Sector: Independent Oil & Gas

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   TherapeuticsMD is a women's healthcare company focused on creating and commercializing products to support the lifespan of women from pregnancy prevention through menopause. Co.'s solutions range from contraceptive to bio-identical hormone therapy pharmaceutical products for the treatment of vasomotor symptoms and dyspareunia. Co.'s contraceptive product consist of ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system) a reversible prescription contraceptive that can prevent pregnancy. Co.'s menopause portfolio includes IMVEXXY (estradiol vaginal inserts) for the treatment of dyspareunia; and BIJUVA (estradiol and progesterone) capsules for the treatment of vasomotor symptoms.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 711,818
Total Buy Value $0 $0 $0 $29,673,332
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 9
Total Shares Sold 0 19,050 19,742 60,493
Total Sell Value $0 $43,683 $46,201 $38,762,036
Total People Sold 0 1 1 6
Total Sell Transactions 0 2 3 15
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 247
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Walker Marlan D Chief Executive Officer   •       –      –    2023-12-07 4 S $2.24 $10,187 D/D (4,550) 62,565 14%     
   Walker Marlan D Chief Executive Officer   •       –      –    2023-12-06 4 S $2.31 $33,496 D/D (14,500) 67,115 15%     
   Walker Marlan D Chief Executive Officer   •       –      –    2023-12-05 4 OE $0.00 $0 D/D 70,000 81,615     -
   Rosen David Efraim 10% Owner   –       –       •   2023-11-15 4 A $2.28 $1,999,998 I/I 877,192 2,946,908     -
   Ziegler Joseph Principal Financial Officer   •       –      –    2023-08-17 4 A $0.00 $0 D/D 7,500 7,500     -
   Rosen David Efraim See Remarks   –       •       •   2023-06-28 4 A $3.68 $1,149,998 I/I 312,525 2,069,716     -
   Walker Marlan D Chief Executive Officer   •       –      –    2023-04-26 4/A S $3.64 $2,518 D/D (692) 11,615     -
   Walker Marlan D Chief Executive Officer   •       –      –    2023-04-26 4/A OE $0.00 $0 D/D 2,744 12,307     -
   Walker Marlan D Chief Executive Officer   •       –      –    2023-04-12 4 S $3.65 $4,276 D/D (1,170) 12,307 -5%     
   Walker Marlan D Chief Executive Officer   •       –      –    2023-04-12 4 OE $0.00 $0 D/D 7,508 13,477     -
   Donegan Michael C Prin. Fin. and Acctg. Officer   •       –      –    2023-04-12 4 OE $0.00 $0 D/D 50,000 61,853     -
   Donegan Michael C Prin. Fin. and Acctg. Officer   •       –      –    2023-01-27 4 S $5.09 $249 D/D (49) 11,853 26%     
   Donegan Michael C Prin. Fin. and Acctg. Officer   •       –      –    2023-01-26 4 S $5.08 $8,371 D/D (1,648) 11,902 12%     
   Donegan Michael C Prin. Fin. and Acctg. Officer   •       –      –    2023-01-26 4 OE $0.00 $0 D/D 5,940 13,550     -
   Donegan Michael C Prin. Fin. and Acctg. Officer   •       –      –    2023-01-24 4 S $5.31 $37 D/D (7) 7,610 16%     
   Donegan Michael C Prin. Fin. and Acctg. Officer   •       –      –    2023-01-23 4 S $5.34 $6,950 D/D (1,302) 7,617 22%     
   Donegan Michael C Prin. Fin. and Acctg. Officer   •       –      –    2023-01-23 4 OE $0.00 $0 D/D 4,365 8,919     -
   Rosen David Efraim See remarks   –       •       •   2022-12-30 4/A D $1,333.00 $38,657,000 I/I (29,000) 0     -
   Rosen David Efraim 10% Owner   –       –       •   2022-12-30 4 S $1,333.00 $38,657,000 I/I (29,000) 0 28%     
   Rosen David Efraim 10% Owner   –       –       •   2022-12-09 4 B $6.09 $90,284 I/I 14,825 1,757,191 1.5 -42%     
   Bernick Brian Co-Chief Executive Officer   •       –      –    2022-12-09 4 S $6.31 $2,020 D/D (320) 3,872 42%     
   Rosen David Efraim 10% Owner   –       –       •   2022-12-08 4 B $5.83 $1,749 I/I 300 1,742,366 1.42 -38%     
   Rosen David Efraim 10% Owner   –       –       •   2022-12-07 4 B $5.66 $113,890 I/I 20,113 1,742,066 1.5 -39%     
   Naughton Gail K Director   –       •      –    2022-12-07 4 S $5.26 $20,635 D/D (3,922) 0 39%     
   Donegan Michael C Interim CFO/CAO/VP of Finance   •       –      –    2022-12-06 4 S $4.78 $4,345 D/D (910) 4,554 33%     
  247 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us